What to Expect When Starting Treatment

  • by  Andrea L.
  •   December 17, 2018

Andrea L. is a paid Advocate for Teva Pharmaceuticals USA, Inc.

When I decided to start a disease modifying therapy, my neurologist sent me home with three huge packets of paperwork and told me to explore my options. After I waded through pages and pages of research and testimonials, I decided to go back to my doctor and asked her to tell me more about my options. She talked me through the choices and then told me about COPAXONE® (glatiramer acetate injection). 

No matter when you make this decision in your therapy journey, it’s an important one that you should discuss with your neurologist and your family. You should do your research and be your own advocate in the doctor’s office.

If you make the decision to start a therapy today, there are a lot of resources available to help you decide which therapy is right for you. With Teva’s Shared Solutions®, you can ask for information and research on COPAXONE®. 

If you choose COPAXONE®, there is additional support available to you. You can request injection training from a nurse who will visit you in your home to teach you how to inject your medication. They are the best teachers with huge hearts and a passion for helping people living with relapsing-remitting multiple sclerosis (RRMS). Lucky us! You can also call 1-800-887-8100 to ask questions over the phone and discuss insurance assistance programs. 

You are not alone. Build your own support group, which starts with the right doctor. Lean on your doctor and others in your life, like family and friends, to help ensure you don’t go through this alone.

If you liked this, sign up to be emailed blog posts from others living with RRMS.

Andrea L.

RRMS Patient

COPAXONE® (glatiramer acetate injection) is a prescription medicine that is used to treat relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.

Do not use COPAXONE® if you are allergic to glatiramer acetate or mannitol.

See Important Safety Information below and full Prescribing Information for Copaxone® (glatiramer acetate Injection).

COP-46013 May 2019
Leave a comment below

More posts you might like

Register today

Get the latest posts and resources from Teva's Lift MS®.

Thank you for your comment!
It is currently being reviewed to make sure it complies with our Rules of Engagement. If it does, it will be shared with the community shortly, so continue to check back. We appreciate you being a part of the Lift MS® community.
0 Comment(s)